Free Trial

Reviva Pharmaceuticals (RVPH) Institutional Ownership

Reviva Pharmaceuticals logo
$1.22 -0.04 (-3.19%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)

Current
Institutional Ownership
Percentage
63.18%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$6.23M
Number of
Institutional Sellers
(last 12 months)
0
Get RVPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RVPH Institutional Buying and Selling by Quarter

Reviva Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833%
5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588%
2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318%
1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062%
11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649%
11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547%
8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071%
7/27/2023Virtu Financial LLC18,448$108K0.0%N/A0.090%
2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118%
2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606%
2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033%
11/7/2022Virtu Financial LLC46,119$73K0.0%N/A0.226%
10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161%
2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364%
2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067%
11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241%
8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742%
8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122%
8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115%
8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734%
8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735%
7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108%
5/21/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397%
5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382%
5/18/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397%
4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162%
(Data available from 1/1/2016 forward)

RVPH Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RVPH shares?

During the previous two years, the following institutional investors and hedge funds held shares of Reviva Pharmaceuticals shares: Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), EMC Capital Management ($613K), Geode Capital Management LLC ($401K), Virtu Financial LLC ($108K), Tang Capital Management LLC ($103K), and Wolverine Asset Management LLC ($85K).Learn more on RVPH's institutional investors.

What percentage of Reviva Pharmaceuticals stock is owned by institutional investors?

63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings.

Which institutional investors have been buying Reviva Pharmaceuticals stock?

The following institutional investors have purchased Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($1.16M), EMC Capital Management ($183.87K), Geode Capital Management LLC ($42.38K), Vanguard Group Inc. ($26.85K), Tang Capital Management LLC ($24.13K), Virtu Financial LLC ($18.45K), and Wolverine Asset Management LLC ($14.55K).

How much institutional buying is happening at Reviva Pharmaceuticals?

Institutional investors have bought a total of 1,488,220 shares in the last 24 months. This purchase volume represents approximately $7.37M in transactions.

Which Reviva Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($224K).

How much institutional selling is happening at Reviva Pharmaceuticals?

Institutional investors have sold a total of 224,000 shares in the last 24 months. This volume of shares sold represents approximately $1.09M in transactions.



This page (NASDAQ:RVPH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners